Related Experiment Video

Updated: Jun 3, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectors

T Schaser1, C Wrede, L Duerner

  • 1Division of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany.

Gene Therapy
|April 8, 2011
PubMed

Insights

This study introduces a novel murine leukemia virus (MLV) vector system for efficient in vivo delivery of RNA interference (RNAi) to cancer cells, significantly downregulating target gene expression and inhibiting tumor growth.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Oncology

Background:

  • RNA interference (RNAi) is a potent tool for gene silencing.
  • Efficient in vivo delivery of RNAi to all tumor cells is crucial for cancer therapy.
  • Current delivery systems face challenges in widespread tumor distribution.

Purpose of the Study:

  • To develop a novel replication-competent murine leukemia virus (MLV) vector for efficient in vivo RNAi delivery.
  • To demonstrate the system's capability to downregulate target genes in tumor tissue.
  • To evaluate the therapeutic potential of this RNAi delivery system in cancer models.

Main Methods:

  • Development of MLV vectors carrying small hairpin RNA (shRNA) expression cassettes.
  • In vitro studies using HT1080 cells expressing GFP or luciferase.
  • In vivo studies using HT1080 tumor xenografts in mice.
  • Assessment of gene and protein expression levels, cell cycle, apoptosis, and tumor growth.

Main Results:

  • MLV vectors achieved >80% GFP and >90% luciferase knockdown in vitro.
  • PLK1 and MMP14 gene and protein expression were significantly reduced.
  • MLV-shPLK1 induced G2-phase arrest and apoptosis; MLV-shMMP14 reduced invasion and tumor growth.
  • In vivo, MLV-shLuc silenced luciferase expression by >80% and MLV-shPLK1 substantially reduced tumor growth.

Conclusions:

  • The developed MLV-based RNAi vector system enables efficient, long-term gene downregulation in vivo.
  • This system demonstrates effective delivery and distribution throughout tumor tissue.
  • The findings highlight the therapeutic relevance of this RNAi delivery system for cancer treatment.

More Related Videos

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection11:28

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...